We are live on ! Find out more
SAM

Sectoral Asset Management Portfolio holdings

AUM $121M
1-Year Est. Return 73.47%
This Fund
S&P 500
This Quarter Est. Return
+1.04%
1 Year Est. Return
+73.47%
3 Year Est. Return
+165.77%
5 Year Est. Return
+169.27%
10 Year Est. Return
+1,136.49%
AUM
$1.2B
AUM Growth
-$33.6M
Cap. Flow
+$15.8M
Cap. Flow %
1.32%
Top 10 Hldgs %
22.6%
Holding
147
New
20
Increased
35
Reduced
44
Closed
20

Sector Composition

Rank Sector Weight
1 Healthcare 94.67%
2 Industrials 4.36%
3 Financials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALNY icon
26
Alnylam Pharmaceuticals
ALNY
$27.5B
$14.3M 1.19%
75,846
-2,000
-3% -$375K
RPTX
27
DELISTED
Repare Therapeutics
RPTX
$13.6M 1.13%
516,485
+104,335
+25% +$3.37M
TGTX icon
28
TG Therapeutics
TGTX
$7.98B
$13.1M 1.09%
394,949
-20,000
-5% -$619K
ZBH icon
29
Zimmer Biomet
ZBH
$17.8B
$12.9M 1.07%
90,846
-412
-0.5% -$60.6K
ALGN icon
30
Align Technology
ALGN
$11.9B
$12.5M 1.04%
18,775
-6,650
-26% -$4.52M
ICLR icon
31
Icon
ICLR
$12.6B
$12.3M 1.02%
46,850
+18,100
+63% +$4.4M
JNJ icon
32
Johnson & Johnson
JNJ
$618B
$12M 1%
74,500
+2,000
+3% +$341K
INSP icon
33
Inspire Medical Systems
INSP
$1.43B
$12M 1%
51,650
-15,600
-23% -$3.26M
BLU
34
DELISTED
BELLUS Health Inc.
BLU
$11.9M 0.99%
1,938,904
+685,964
+55% +$2.6M
OLK
35
DELISTED
Olink Holding AB (publ) American Depositary Shares
OLK
$11.8M 0.99%
488,642
-125,383
-20% -$3.94M
LH icon
36
Labcorp
LH
$25.2B
$11.7M 0.97%
48,320
+7,915
+20% +$1.99M
NVTA
37
DELISTED
Invitae Corporation
NVTA
$11.7M 0.97%
410,763
FATE icon
38
Fate Therapeutics
FATE
$286M
$11.4M 0.95%
193,160
+46,160
+31% +$3.62M
UNH icon
39
UnitedHealth
UNH
$380B
$11.3M 0.94%
28,800
TRML
40
DELISTED
Tourmaline Bio
TRML
$11M 0.92%
81,416
+10,316
+15% +$1.41M
NKTX icon
41
Nkarta
NKTX
$149M
$10.7M 0.89%
384,364
-26,216
-6% -$831K
TMO icon
42
Thermo Fisher Scientific
TMO
$210B
$10.7M 0.89%
18,650
+8,250
+79% +$4.53M
CTLT
43
DELISTED
CATALENT, INC.
CTLT
$10.4M 0.87%
78,250
-4,000
-5% -$499K
PODD icon
44
Insulet
PODD
$11.4B
$9.88M 0.82%
34,754
ABBV icon
45
AbbVie
ABBV
$446B
$9.6M 0.8%
89,000
COO icon
46
Cooper Companies
COO
$13.9B
$9.46M 0.79%
91,520
-4,800
-5% -$512K
RPID icon
47
Rapid Micro Biosystems
RPID
$104M
$9.44M 0.78%
+510,835
New +$10.6M
CRL icon
48
Charles River Laboratories
CRL
$11.1B
$9.41M 0.78%
22,800
LLY icon
49
Eli Lilly
LLY
$1.01T
$9.41M 0.78%
40,715
+3,700
+10% +$913K
AVAH icon
50
Aveanna Healthcare
AVAH
$2.04B
$9.4M 0.78%
1,172,609
-485,391
-29% -$4.7M

Similar funds

Sectoral Asset Management's Q3 2021 Portfolio in Review

As of Q3 2021, Sectoral Asset Management held 147 positions worth $1.2B, down 2.7% from $1.24B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Sectoral Asset Management's Q3 2021 filing shows 20 new, 35 increased, 44 reduced and 20 closed positions. Its largest new stake was eFFECTOR Therapeutics, Inc. Common Stock: 115,310 shares worth $40.5M. The largest sale was Teleflex, an estimated $21.8M.

By sector, the portfolio is most concentrated in Healthcare at 95% of assets, up from 94% a quarter earlier, followed by Industrials and Financials.

  • Sectoral Asset Management's largest Q3 2021 buy was eFFECTOR Therapeutics, Inc. Common Stock: 115,310 shares worth $40.5M.
  • Sectoral Asset Management added most to Treace Medical Concepts in Q3 2021, an estimated $8.26M increase.
  • Sectoral Asset Management's biggest Q3 2021 reduction was Teleflex, cutting an estimated $21.8M.
  • Sectoral Asset Management fully exited Oak Street Health, Inc. in Q3 2021, selling an estimated $18.8M.
  • Sectoral Asset Management's ten largest holdings make up 23% of its $1.2B portfolio in Q3 2021.
  • Sectoral Asset Management opened 20 new positions and closed 20 in Q3 2021.
  • Sectoral Asset Management's portfolio value fell 2.7% quarter-over-quarter to $1.2B.

Based on Sectoral Asset Management's 13F filing for Q3 2021, filed 15 Nov 2021.